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Abstract
The low-risk human papillomavirus type 2a (HPV2a) has been found associated with benign skin epithelial tumors and has only been
very rarely identified in malignized epithelia. Here we report the identification of the E5 gene of HPV2a and demonstrate that the protein
is mainly expressed in the Golgi apparatus of transfected cells, similar to the known high-risk types E5 proteins. Further, we present
experimental evidence demonstrating that HPV2a E5, similar to HPV16 E5, is able to modulate EGF-mediated erk1/2 MAP kinase
activation and to down-regulate the expression of MHC class I molecules at the plasma membrane. Thus, the E5 gene of at least one
cutaneous low-risk HPV type displays similar biological characteristics to those described for the high-risk type HPV16.
© 2003 Elsevier Inc. All rights reserved.
Introduction
Human papillomaviruses (HPVs) have been associated
with benign and malignant cellular growth. Based on this
association, two different types of HPVs have been de-
scribed: high-risk type, found mostly associated with carci-
nomas of the cervix and neck; and low-risk type, found
primarily in benign proliferating lesions (zur Hausen, 2002).
Two main oncogenes have been identified in all HPV
types so far analyzed, the E6 and E7 genes. Besides these
genes, another one, called E5, has been characterized in
several high- and low-risk HPV types. E5 possesses only
weak oncogenic properties, although it is able to transform
mouse fibroblasts and human keratinocytes (Leptak et al.,
1991; Leechanachai et al., 1992). In addition, it has been
shown that HPV16 E5 increases the transforming potential
of the E7 oncogene (Bourvard et al., 1994). This is in
contrast to the situation found in BPV1, where the E5 gene
is a strong oncogene and is responsible for the appearance
of malignant growth (Schlegel et al., 1986). In all HPV
types so far analyzed the E5 protein has been found to be a
membrane protein and associated mainly with the Golgi
apparatus and endosomes (Conrad et al., 1993; Oetke et al.,
2000). The most pregnant characteristic of all described E5
proteins is its hydrophobicity. This hydrophobicity has
hampered the production of antibodies, making E5 research
a rather difficult task. In HPV16, the most studied type, E5
is a small protein, 83 amino acids long, possessing three
well-defined hydrophobic regions and probably only one
transmembrane region (Bubb et al., 1988). Whereas results
have been published about the structure of the BPV1 E5
protein, information on HPV E5 proteins is scarce (Surti et
al., 1998). Circular dichroism analysis of HPV16 E5 pep-
tides suggests that the conformation of the protein is depen-
dent on interactions between the three hydrophobic seg-
ments (Alonso and Reed, 2002).
The biological effects of high-risk E5 proteins include a
modulation of ligand-dependent and independent EGFR ac-
tivation (Leechanachai et al., 1992; Straight et al. 1993;
Crusius et al., 1997, 1998, 2000), an inhibition of the gap
junction mediated cell–cell communication (Oelze et al.,
1995), and to confer cell resistance to apoptosis (Kabsch
and Alonso, 2002; Zhang et al., 2002). Little is known about
the molecular mechanisms by which E5 produces the above
described effects (for reviews see Auvinen et al., 1997;
DiMaio and Mattoon, 2001). It seems that HPV6 E5 is able
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to bind the EGF receptor, in contrast with HPV16 E5,
although alternative results have been published (Conrad et
al., 1994; Hwang et al., 1995). In addition, it has been
proposed that binding of HPV16 E5 to the 16-kDa subunit
of the proton ATPase is responsible for endosomal acidifi-
cation, although other reports show that binding of E5 to the
16-kDa subunit does not disturb the function of the ATPase
(Straight et al., 1995; Ashbey et al., 2001). Interestingly,
also low-risk types E5 proteins are able to bind to the 16K
protein, being this binding probably related to the effect of
the protein on EGF receptor recycling or altered transport of
MHC class I molecules (Conrad et al., 1993). HPV11 E5
has been shown to suppress p21Cip expression, induce
anchorage-independent growth, and stimulate c-fos early
gene transcription (Tsao et al., 1996; Chen et al., 1996a,b).
We were interested in the significance of E5 proteins of
HPV types not associated with malignant growth. We hy-
pothesized that the biological effects of E5 would be prob-
ably similar in both high- and low-risk types. This assump-
tion was based on the fact that the E5 gene is strongly
transcribed in low-grade squamous lesions (Chow et al.,
1987; Stoler et al., 1992) and that it is frequently deleted
upon incorporation of the viral genome into the host DNA,
suggesting that the protein is no longer required in the later
stages of tumor progression (Schwarz et al., 1985; Bauer-
Hofmann et al., 1996).
To analyze the characteristics of a cutaneous type E5
protein we chose the only marginally characterized HPV2a,
known to be preferentially associated with warts of the
human skin and very rarely found in oral carcinomas (Orth
et al., 1977; Adler-Storthz et al., 1986; Obalek et al., 1993;
Keefe et al., 1994; Lu et al., 1996). An important issue in
this approach was the identification of the E5 gene of
HPV2a, a type not investigated so far. We analyzed the
genome of HPV2a and detected two open reading frames
with coding capacity for two small proteins.
Here we present experimental evidence showing that one
of these reading frames codes for a putative HPV2a E5
protein and that this protein displays similar characteristics
and effects as the E5 proteins of the high-risk types.
Results
Cloning of the 48a and the 38a putative E5 reading
frames and characteristics of the proteins
The sequence of the human papillomavirus type 2a com-
prises 8670 nucleotides and computer analysis of its se-
quence reveals the presence of putative reading frames for
all major papillomavirus proteins (Hirsch-Behnam et al.,
1990). In the genomic position where the E5 reading frame
of the high-risk types are found, four different open reading
frames could be identified, two of them with a coding
capacity for only a few amino acids (Hirsch-Behnam et al.,
1990). The two other reading frames begin with a methio-
nine start codon resembling the characterized E5 genes of
the high-risk HPV types. These two reading frames have
coding capacity for two proteins with 48 and 38 amino
acids, respectively.
Since all known E5 reading frames start with a methio-
nine codon, we decided to discard the two small reading
frames and concentrate to the two larger putative genes. In
Fig. 1 the characteristics of the putative reading frames and
proteins are shown. In Fig. 1D a Kyte–Doolittle hydropho-
bic analysis of the 48a protein is shown. The protein dis-
plays a major hydrophobic region, with a less hydrophobic
small tract of 10 amino acids at the N-terminal end. The
orientation of the protein in the membrane is unknown and
a computer analysis of the sequence reveals the presence of
a putative trans-membrane region at the C-terminal end (not
shown).
Comparative sequence analysis of HPV2a-48a and the
potential E5 proteins of all other HPV types reveals a strong
homology to HPV27 and HPV57 putative E5 proteins (Fig.
1E). All three types have earlier been classified as members
of the same branch of the phylogenetic tree (Chan et al.,
1997).
HPV2a 48a E5 protein mainly localizes to the Golgi
apparatus
To determine the cellular location of the putative E5
proteins, the pGFP fusion recombinants for the 38a and the
48a genes were transfected into 293T or the human kera-
tinocyte cell line HaCaT. As shown in Fig. 2A, most of the
fluorescence in plasmid pGFP-48a transfectants accumu-
lated at the perinuclear region of the cells. These results are
consistent with a location of the 48a protein in the Golgi
apparatus, as also found for the BPV1-E5 and HPV16-E5
genes. To further substantiate these results, we performed
double immunofluorescence using antibodies to 58K, a cel-
lular protein which has been localized to the Golgi appara-
tus (Martı´nez-Menarguez et al., 1996; Oetke et al., 2000).
As shown in Fig. 2C, most of the fluorescence of GFT-E5-
48a fusion protein and of 58K colocalize, indicating that
most of the protein is indeed at the Golgi apparatus in a
similar distribution as found for GFP-HPV16 E5 fusion
proteins (Oetke et al., 2000). To further substantiate these
results and avoid putative effects of the long GFP tag on
protein location, we transfected cells with the Flag-48a
recombinant and analyzed colocalization of the Flag epitope
with the 58K Golgi protein. As shown in Figs. 2D–F, a clear
colocalization between the Flag epitope and 58K could also
be observed, thus indicating that the length of the tag had no
effect on the cellular localization of the protein. Further, in
cells transfected with large amounts of the recombinant
DNA the protein is found not only at the Golgi but also
associated with the ER or with the endosomes forming large
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aggregates. No differences in the location in either HEK-
293T or HaCaT cells were noted.
Immunofluorescence analysis using antibodies to
Lamp-2, a known lysosomal marker, shows no colocaliza-
tion with E5-48a (data not shown), further substantiating the
finding that the localization of the low-risk E5 protein is
very similar to that described for the high-risk types E5
protein.
In GFP-E5-38a transfected cells, fluorescence was dis-
tributed homogeneously in the cytoplasm and no location of
the protein in any specific cellular compartment was noticed
(Fig. 2G). Thus, the HPV2a-E5-38a protein does not share
the characteristic cellular location found by all E5 types so
far analyzed. This finding correlates with the different hy-
drophobicity profiles of both proteins, being the 38a rather
a hydrophylic peptide, in contrast to the 48a peptide (see the
paragraph above). On the basis of these results we consider
the 48a protein to represent the genuine E5 gene and used it
for all further experiments.
HPV2a-E5 protein expression in transfected cells
The results of the immunofluorescence prompted us to
analyze the expression characteristics of the protein in trans-
fected cells. HEK-293T cells were transfected with either
the GFP fusion proteins for the 48a or the 38a genes and
protein extracts were blotted with an antibody specific for
the GFP moiety. As shown in Fig. 3A, bands with compat-
ible molecular weight with the fusion proteins were ob-
served, thus demonstrating that the cells synthesize the
corresponding fusion proteins. We further transfected cells
with the pCI-Flag-48a construct; again cell extracts were
prepared and reacted with the N2 anti-flag antibody
(Sigma). As shown in Fig. 3B, a band with an apparent
molecular mass of 7 kDa is observed, which is absent in
vector-transfected cells. Being the theoretical molecular
mass of the protein 5.56 kDa, the abnormal migration ob-
served in acrylamide gels is probably the result of the high
hydrophobicity of the protein. Thus, these results demon-
Fig. 1. Characteristics of the HPV2a E5 protein. Location of the ORFs in HPV2a in the “E5-region” of the high-risk HPV types (A). The DNA sequence
of both reading frames starting with a methionine and its translation to protein are given in B and C. In D the hydrophobicity of the protein analyzed by the
Kyte–Doolittle algorithm is shown. Two hydrophobic regions (amino acids 10 to 20 and amino acids 22 to 44) are evident. In E a comparison of the
HPV2a-E5-48a with all putative E5 reading frames of high- and low-risk HPV types is shown.
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strate that HPV2a-E5-transfected cells express a protein
with the putative characteristics of the E5 reading frame.
HPV2a-E5 modulates MAP kinase activation
One of the major questions concerning the E5 protein of
the low-risk HPV types is whether this protein will produce
the same or similar biological effects on the infected cells.
It has been shown that one of the major effects of HPV16
E5, the most studied E5 protein so far, is an overactivation
of the EGF receptor and therefore a strong stimulation of the
erk1/2 MAP kinase pathway (Leechanachai et al., 1992;
Straight et al., 1993; Gu and Mathlashewski, 1995; Crusius
et al., 1998).
To analyze the effects of HPV2a E5 on MAP kinase
activation, 293T cells were transiently transfected with the
pCI-Flag-48a gene and then treated with EGF for 10 min.
As a control, cells were transfected with the HPV16 E5
gene, known to strongly increase erk1/2 activation in a
EGFR-dependent manner (Gu and Matlasehwsky, 1995;
Crusius et al., 1998). Cell extracts were prepared and pro-
teins were blotted with an antibody recognizing specifically
the activated form of the kinase. As shown in Fig. 3C
HPV2a E5, similar to HPV16 E5, is able to increase EGF-
mediated erk1/2 phosphorylation in transfected cells. This
modulation is mediated by a ligand-dependent increased
tyrosine phosphorylation of the EGF receptor in transfected
cells, as already demonstrated for HPV16 E5 (results not
shown) (Crusius et al., 1998). Thus, our experiments dem-
onstrate that the E5 protein of a low-risk HPV type exerts
similar effects on ligand-mediated signal transduction
through tyrosine kinase receptors as the high-risk types E5
proteins.
HPV2a-E5 down-regulates HMC-class I expression at the
plasma membrane
It has recently been described that BPV1 E5 is able to
down-regulate surface expression of MHC class I molecules
(Ashrafi et al., 2001; Marchetti et al., 2002). This modula-
tion seems to be due to a defective transport of the MHCs
from the ER-Golgi to the plasma membrane rather than to a
specific protein degradation (Marchetti et al., 2002). In
addition it seems that this effect is also observed in cells
expressing HPV16 E5, showing that the effect is not re-
stricted to the bovine viral protein (Campo, 2002). We
therefore sought to analyze whether HPV2a E5 was also
able to down-modulate surface appearance of MHC-I mol-
ecules at the plasma membrane. HEK-293T cells were
transfected with HPV2a-E5 and after 24 h they were stained
with antibody B9.12, known to recognize all human MHC
class I molecules (Rebai and Malissen, 1983). As sown in
Fig. 3. Expression of HPV2a-E5 fusion proteins and effect of E5-48a on
MAP kinase activation. HEK-293T cells were transfected with the fusion
clones GFP-38a, GFP-48a, or the empty vector. After 48 h protein extracts
were prepared and immunoblotted with anti-GFP antibodies (A). Cells
were transfected with the pFlag-CMV-48a or the empty vector and proteins
extracts were prepared as before. Immunoblots were performed using the
N2 anti-flag antibody. A clear reacting band at the MW expected for the
E5-48a is observed. M: marker proteins (B). Cells transfected with HPV16-
E5, pFlag-CMV-48a, or the empty vector were treated or not for 10 min
with EGF, and immunoblots were performed with an antibody recognizing
specifically the dual phosphorylated form of the kinase (C). The blot was
stripped and reacted with an antibody recognizing total erk1/2 kinases to
prove for similar loading (C, bottom).
Fig. 2. Localization of HPV2a E5 in transfected cells. HaCaT or HEK-
293T cells were seeded on glass coverslips, transfected with pFlag-E5-48a
(A–C), GFP-E5-48a (D–F), or GFP-E5-38a (G) and 24 h later fixed and
immunostained. Expression of E5 was monitored by immunostaining with
the M2 anti-Flag antibody (A–C) or analyzing the green fluorescence
(D–G). Location of the E5-48a protein is shown in A and D. The 58K
protein is shown in B and E. C and F show the merge picture. In cells
transfected with the GFP-E5-38a recombinant the expression of the fusion
protein was distributed over the entire cytoplasm (G).
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Fig. 4, FACS analysis of the cells shows a shift of the MHC
class I amount in E5-transfected cells, indicating that
HPV2a affects plasma membrane expression. The reduction
in plasma membrane expression in HPV2a E5-expressing
cells varied between 30 and 36% in three different trans-
fection experiments, whereas the reduction observed in
HPV16-transfected cells was between 48 and 54%. Since
the transfection efficiency is no less than 60%, we can
conclude that the down-regulation of surface expression by
HPV2a E5 is a relatively efficient process. Further, incuba-
tion of E5- and empty vector-transfected cells with an
IgG2a isotype irrelevant antibody does not modify the rel-
ative fluorescence intensity of the cells, indicating that the
down-regulation of MHC class I molecules is isotype-inde-
pendent (see Fig. 4, left curves).
To know whether this down-regulation was the result of
a general reduction of MHCs and not only to reduced
plasma membrane expression, we analyzed the total amount
of MHCs by Western blot using total protein extracts from
transfected cells. As shown in Fig. 4, cells transfected with
either the HPV16 or the HPV2a E5 recombinants (inset,
lanes 1, 2) contain similar MHC amounts as cells trans-
fected with the empty vector (inset, lane 4). These results
strongly suggest that HPV2a E5 uses similar mechanisms to
down-regulate MHC surface expression as BPV1 E5 (Mar-
chetti et al., 2002). We therefore conclude that HPV2a E5
plays a similar role in the processing of MHC molecules as
BPV1 or HPV16 E5.
Discussion
Most of the work published so far on the biological
effects of papillomavirus E5 proteins has been performed
with the BPV1 protein. In BPV1, E5 has been found to be
the major oncogene, in contrast to the situation found in
human papillomaviruses, where E5 is only a weak oncogene
and probably plays only a role in the first stages after
infection.
Only in a few high-risk HPV types a clearly defined E5
gene has been described. In addition, similarities between
potential E5 genes of high- and low-risk HPV types have
been considered to be rather small. In the low-risk type
HPV2a no defined open reading frame had been identified
which may code for a protein with the characteristics of the
so far identified E5 proteins. In the DNA sequence of
HPV2a, four open reading frames have been identified,
located between the end of E2 and L2 proteins. Taking into
account the characteristics of the known E5 proteins, we
postulated that the putative HPV2a E5 should contain a
methionine start codon. From the two reading frames ful-
filling this condition, the 38a frame codes for a putative
protein which shows no characteristics typical for the
known E5 proteins. The other reading frame has coding
potential for a protein with some characteristics similar to
those found by the membrane-associated proteins of the
high-risk viral types. A computer comparison of the
HPV2a-E5 48a reveals a strong similarity to the putative E5
proteins from types HPV-27 and HPV-57. This is most
interesting since published results have shown that all three
HPV types fall within one group of the phylogenetic tree
(Chan et al., 1997). Thus it seems that E5 has evolved
following the general pattern of sequence evolution of hu-
man papillomaviruses.
Immunofluorescence experiments further substantiated
that the 48a reading frame corresponds to a E5 gene. Our
Fig. 4. Plasma membrane down-regulation of MHC class I in E5-48a-
transfected cells. HEK-293T cells were transfected with either HPV-2a-E5
(A), or HPV16-E5 (B) using calcium phosphate or Lipofectamine 2000.
Cell were grown for 24 h and then stained with antibody B9.12 as de-
scribed under Materials and methods. Thin lines, cells transfected with the
empty vector. Thick lines, cells transfected with the corresponding E5
reading frames. Left curves in A, cellular fluorescence background using
an irrelevant IgG2a antibody. The absolute values of the analysis of all four
cell populations of one experiment are shown underneath of B. The ex-
periment was repeated three times with similar results. Triplicate values
were measured each time. Analysis of the values using the Kolmogorov–
Smirnov algorithm gives P  0.001 for both transfectant types, indicating
that the differences observed are significant. Inset, Western blot analysis of
total cellular proteins from cells transfected with HPV16 E5 (1), HPV2a E5
(2), empty vector transfected cells (4). Lane 3 shows the migration char-
acteristics of MHC class I in protein extracts of T2 lymphocytes. Blots
were reacted with antibody HC-A2 recognizing human HLA antigens. mfi:
mean fluorescence intensity. Geo mean: background fluorescence.
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results demonstrate that only the 48a-amino-acids-long pro-
tein localized to the Golgi apparatus, similar to all other E5
proteins so far described. The 38a protein was distributed all
over the cytoplasm and did not colocalize with any mem-
brane structure within the cells. Thus, from these results we
concluded that the cloned 48a sequence represents the bona
fide HPV2a E5 gene. Identification of the putative E5 pro-
tein should be not only accomplished by the physical char-
acteristics of the protein but also from its biological activity.
We argued that if the cloned reading frame represents the
true E5 gene, the proteins would be, at least to some extent,
similar in its biological characteristics to the already known
high-risk types E5 proteins.
One of the major properties of high-risk E5 proteins is its
effect on the activation of membrane-bound tyrosine kinase
receptors and MAP kinases (Leechanachai et al., 1992;
Straight et al., 1993; Gu and Mathlashewski, 1995; Crusius
et al., 1998). Similar to HPV16 E5, HPV2a E5 increases
activation of the MAP kinases erk1/2 in a EGF-dependent
manner (see Fig. 3C) and thus has the potential to modulate
transcription of early genes, as HPV16 do (Gu and Math-
lashewski, 1995; Crusius et al., 1998). Taken together, our
results show that the effect of E5 proteins on MAP kinase
activation is not an exclusive property of the high-risk types,
and that the cutaneous type 2a E5 protein is also able to
modulate phosphorylation of MAP kinases erk1/2 in a li-
gand-dependent manner.
A further similarity between the E5 proteins of low and
high risk is suggested by the results of the protein on MHC
class I processing. Recent reports have shown that BPV and
HPV16 E5 are able to down-regulate MHC class I mole-
cules at the plasma membrane (Ashrafi et al., 2001; Mar-
chetti et al., 2002; Campo, 2002). Our results show that
HPV2a E5 also displays a similar effect and that the amount
of plasma membrane-associated MHC molecules decrease
after transfection of the gene. This change seems to be
primarily due to a disturbed transport process and not to
increased protein degradation in E5-transfected cells, as
already described for BPV1 E5 (Marchetti et al., 2002).
Whether this decrease in surface MHCs plays any role in the
capacity of the cells to present antigens remains to be
elucidated. Further, no information is presently available as
whether high-risk E5 types may modulate antigen presen-
tation. In this context it is worth mentioning that in prema-
lignant lesions and carcinomas of the cervix a reduction in
the MHC content has been described (Ritz et al., 2001; Ryu
et al., 2001). This reduction is independent of the HPV type
present in the particular lesion, supporting the data pre-
sented in this article (Cromme et al., 1993).
The fact that the E5 proteins of both high and low risk
display similar effects in transfected cells opens the ques-
tion of the biological significance of E5 during malignant
growth. Our results suggest that the effects described for E5
proteins are not linked to any process associated with ma-
lignization, and that they should rather have a role during
the first phases of cellular instability immediately after viral
infection. This is further supported by results showing that,
in contrast to the other two oncogenic proteins of the high-
risk viruses E6 and E7, E5 is no longer necessary once
malignant growth has been established (Schwarz et al.,
1985; Bauer-Hofmann et al., 1996). Thus, the effects of E5
would be common to all HPV types and related to the first
stages of viral infection. E5 protein would prepare the cells
for the next steps in the process of transformation but
without playing any role in the malignization step. In sum-
mary, our results show that a gene with similar character-
istics to the high-risk HPV types E5 is present in the cuta-
neous type HPV2a type, and that the biological effects of
this gene are similar to those ascribed to HPV16 E5.
Materials and methods
Cloning of HPV2a E5 genes
The reading frames of the two putative E5 genes were
cloned in vector pGFP-C1 and in vector pFlag-CMV2,
using the corresponding primers for PCR reactions flanked
by EcoRI-BamHI restriction sites. The first reading frame
extends from nucleotide 4163 to nucleotide 4310 and has a
coding capacity for 48 amino acids (E5-48a). The second
reading frame comprises the fragment between nucleotides
3883 and 4002 and codes for a protein with 38 amino acids
(E5-38a). All clones were verified by DNA sequencing.
Transfection experiments and immunofluorescence
Transfections using either the GFP-E5 fusion genes or
the pFlag-CMV2-tagged genes were performed using the
calcium phosphate method or Lipofectamine 2000 (Invitro-
gen). Cells were plated the day before transfection so that
70% confluency was reached the next day. Under the con-
ditions used in our experiments we obtained a transfection
efficiency of up to 80% for HEK-293T cells and 10% for
HaCaT cells.
For immunofluorescence HEK-293T or HaCaT cells
were grown on coverslips, transfected with the correspond-
ing GFP fusion recombinants, and fixed with 3% parafor-
maldehyde 24 h thereafter. To analyze colocalization be-
tween the 58K Golgi protein and E5, coverslips were
incubated with anti-58K antibodies (Sigma, Mu¨nchen), the
M2 anti-Flag antibody (Sigma), or Lamp-2 antibodies
(Santa Cruz, Heidelberg), and were washed, and incubated
with a secondary antibody labeled with Alexa-488. Pictures
were taken with a Leica DM-IRBE confocal microscope.
Protein extracts for Western analysis were prepared 24 or
48 h after transfection. The presence of HPV2a-E5 in trans-
fected cells was demonstrated by separating the proteins
extracts on 18% polyacrylamide gels, blotting onto PVDF
membranes, and incubating the membranes with the Flag
N2 antibody (Sigma).
577W. Cartin, A. Alonso / Virology 314 (2003) 572–579
Activation of MAP kinases
To analyze activation of MAP kinases erk1/2, HEK-
293T cells were transfected transiently with the pFlag-
CMV-E5 clone and after 24 h protein extracts were pre-
pared in 1% SDS. Proteins were separated on 10%
polyacrylamide gels and blotted onto nitrocellulose mem-
branes. Incubation with an antibody recognizing specifically
the phosphorylated forms of erk1/2 (Cell Signaling, Frank-
furt) was performed as recommended by the vendor. Similar
loading of the gels was proved by stripping the membranes
and reincubating them with an antibody recognizing total
erk1/2 proteins.
Reacting bands were revealed with the ECL or ECL-Plus
reagent. When using ECL-Plus in blots, the PhosphoImager
(Molecular Dynamics, Strom 860) at channel 2 Blue, in the
Fluorescence Acquisition Mode, was used together with the
Image-Quant software.
FACS analysis
Surface expression of MHC class I molecules in trans-
fected HEK-293T cells was analyzed by fluorescence-acti-
vated cell sorting (FACS). Cells were detached from the
plate after incubation with PBS containing 0.25% EDTA for
2 min. Then 5  105 cells were suspended in 100 L of
B9.12 (IgG2a) antibody and incubated for 30 min on ice.
After a washing step with FACS buffer (PBS containing 3%
FCS, 0.02% sodium azide) a fluorescein isothyocyanate
(FITC) conjugated secondary antibody was added, and the
cells were stained for 30 minute on ice. The washed cells
were then suspended in 400 L of cold FACS buffer. For
each sample, 10,000 single events were analyzed with a
flow cytometer (Becton–Dickinson, Mountain View, CA)
by using Cell Quest software and the FITC detector filter
FL-1.
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